2 results
Approved WMOPending
Determining the effectiveness of commonly used premedicating agents in reducing subclinical stress responses in newborns during intubation.
Approved WMOCompleted
Primary objectives * surrogate endpoint (at interim analysis)To evaluate the efficacy of elafibranor QD for 72 weeks versus placebo on resolution of NASH without worsening of fibrosis.* Resolution of NASH is defined as the disappearance of…